Evidence map›Paper›PMID 28766097›Full record

ArticleJournal of computer-aided molecular design2018

Ranking docking poses by graph matching of protein-ligand interactions: lessons learned from the D3R Grand Challenge 2.

Priscila da Silva Figueiredo Celestino Gomes, Franck Da Silva, Guillaume Bret, Didier Rognan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Priscila da Silva Figueiredo Celestino GomesLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS-Université de Strasbourg, 67400, Illkirch, France.
Franck Da SilvaLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS-Université de Strasbourg, 67400, Illkirch, France.
Guillaume BretLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS-Université de Strasbourg, 67400, Illkirch, France.
Didier RognanLaboratoire d'Innovation Thérapeutique, UMR 7200 CNRS-Université de Strasbourg, 67400, Illkirch, France. rognan@unistra.fr.ORCID 0000-0002-0577-641X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel docking challenge has been set by the Drug Design Data Resource (D3R) in order to predict the pose and affinity ranking of a set of Farnesoid X receptor (FXR) agonists, prior to the public release of their bound X-ray structures and potencies. In a first phase, 36 agonists were docked to 26 Protein Data Bank (PDB) structures of the FXR receptor, and next rescored using the in-house developed GRIM method. GRIM aligns protein-ligand interaction patterns of docked poses to those of available PDB templates for the target protein, and rescore poses by a graph matching method. In agreement with results obtained during the previous 2015 docking challenge, we clearly show that GRIM rescoring improves the overall quality of top-ranked poses by prioritizing interaction patterns already visited in the PDB. Importantly, this challenge enables us to refine the applicability domain of the method by better defining the conditions of its success. We notably show that rescoring apolar ligands in hydrophobic pockets leads to frequent GRIM failures. In the second phase, 102 FXR agonists were ranked by decreasing affinity according to the Gibbs free energy of the corresponding GRIM-selected poses, computed by the HYDE scoring function. Interestingly, this fast and simple rescoring scheme provided the third most accurate ranking method among 57 contributions. Although the obtained ranking is still unsuitable for hit to lead optimization, the GRIM-HYDE scoring scheme is accurate and fast enough to post-process virtual screening data.

Indexed as

Drug DesignDrug DiscoveryMolecular Docking SimulationBinding SitesComputer-Aided DesignCrystallography, X-RayDatabases, ProteinHumansLigandsProtein BindingProtein ConformationReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearThermodynamicsLigandsReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearD3RDockingDrug discovery data resourceGrand Challenge

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.